Tag: telaglenastat

Pediatric renal and thyroid cancer rates increase

Telaglenastat addition to cabozantinib did not demonstrate benefit in pre-treated advanced renal cell carcinoma

byJohan Pushaniand1 others

September 12, 2022

1. Telaglenastat addition to cabozantinib did not show improvements in clinical benefit. 2. Adverse events of grades 3 or 4 ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

#VisualAbstract: Daratumumab Reduces Risk of Progression in High-Risk Smoldering Multiple Myeloma
Heated mittens not found to improve physical hand function in patients with osteoarthritis
Therapeutic-dose anticoagulation reduces mortality risk compared with prophylactic-dose anticoagulation in patients hospitalized for COVID-19

No Result

View All Result